Literature DB >> 24894408

The unmet needs of all adults with ADHD are not the same: a focus on Europe.

Ylva Ginsberg1, Kathleen Marie Beusterien, Kaitlan Amos, Claude Jousselin, Philip Asherson.   

Abstract

This review discusses the unmet needs in adult ADHD subgroups in Europe: adolescents in transition, adult patients, employees, older adults, and those in the criminal justice system. Analysis of the literature and an ADHD web forum was conducted. The visibility of adult ADHD remains low, and finding professionals able to diagnose is difficult for both adolescents as well as adults. Many ADHD cases go undiagnosed and untreated; ADHD may be mistaken for other common mental health conditions or missed in the presence of comorbidities. Pharmacological and psychosocial treatment services are very limited. Most employers do not understand how to address ADHD, and employees fear stigmatization. Older age individuals (>60 years) may feel worse with unrecognized ADHD, and those incarcerated with ADHD are likely to cost disproportionately more than their peers, with high recidivism rates. Strategies to address unmet needs and accommodate ADHD adults need not be expensive or time consuming to implement.

Entities:  

Keywords:  Europe; adolescents; adult ADHD; health services; unmet needs

Mesh:

Year:  2014        PMID: 24894408     DOI: 10.1586/14737175.2014.926220

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  11 in total

1.  The intraindividual impact of ADHD on the transition of adulthood to old age.

Authors:  Florence Philipp-Wiegmann; Petra Retz-Junginger; Wolfgang Retz; Michael Rösler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-10-05       Impact factor: 5.270

2.  Standardised assessment of functioning in ADHD: consensus on the ICF Core Sets for ADHD.

Authors:  Sven Bölte; Soheil Mahdi; David Coghill; Susan Shur-Fen Gau; Mats Granlund; Martin Holtmann; Sunil Karande; Florence Levy; Luis A Rohde; Wolfgang Segerer; Petrus J de Vries; Melissa Selb
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-02-12       Impact factor: 4.785

3.  Educational delay and attainment in persons with neurofibromatosis 1 in Denmark.

Authors:  Karoline Doser; Line Kenborg; Elisabeth Wreford Andersen; Pernille Envold Bidstrup; Anja Kroyer; Hanne Hove; John Østergaard; Sven Asger Sørensen; Christoffer Johansen; John Mulvihill; Jeanette Falck Winther; Susanne Oksbjerg Dalton
Journal:  Eur J Hum Genet       Date:  2019-02-28       Impact factor: 4.246

4.  ADHD in Germany: Trends in Diagnosis and Pharmacotherapy.

Authors:  Christian J Bachmann; Alexandra Philipsen; Falk Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2017-03-03       Impact factor: 5.594

Review 5.  Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes.

Authors:  Jose Martinez-Raga; Amparo Ferreros; Carlos Knecht; Raquel de Alvaro; Eloisa Carabal
Journal:  Ther Adv Drug Saf       Date:  2016-11-29

6.  An international clinical study of ability and disability in ADHD using the WHO-ICF framework.

Authors:  Soheil Mahdi; Nadia Ronzano; Ane Knüppel; José Carlos Dias; Ayman Albdah; Lin Chien-Ho; Omar Almodayfer; Annet Bluschke; Sunil Karande; Huei-Lin Huang; Hanna Christiansen; Mats Granlund; Petrus J de Vries; David Coghill; Rosemary Tannock; Luis Rohde; Sven Bölte
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-02-17       Impact factor: 4.785

7.  Does level of attention deficit-hyperactivity disorder symptoms predicts poor transition into adulthood?

Authors:  Stéphanie Baggio; Joseph Studer; Ana Fructuoso; Véronique S Grazioli; Patrick Heller; Hans Wolff; Gerhard Gmel; Nader Perroud
Journal:  Int J Public Health       Date:  2018-07-25       Impact factor: 3.380

8.  Attention deficit hyperactivity disorder symptom self-report in adults in Kenya and its associated risk factors, an analysis from a household survey in a demographic surveillance site.

Authors:  R Jenkins; C Othieno; L Ongeri; B Ogutu; P Sifuna; J Mboroki; R Omollo
Journal:  Glob Ment Health (Camb)       Date:  2015-07-29

Review 9.  Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review.

Authors:  Rafał R Jaeschke; Ewelina Sujkowska; Magdalena Sowa-Kućma
Journal:  Psychopharmacology (Berl)       Date:  2021-08-26       Impact factor: 4.530

10.  ADHD as a Risk Factor for Infection With Covid-19.

Authors:  Eugene Merzon; Iris Manor; Ann Rotem; Tzipporah Schneider; Shlomo Vinker; Avivit Golan Cohen; Ari Lauden; Abraham Weizman; Ilan Green
Journal:  J Atten Disord       Date:  2020-07-22       Impact factor: 3.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.